RooLife Group Launch the First Online Pharmacy Store in China
ROOLIFE GROUP LIMITED (ASX: RLG) (RooLife Group or “Company”) has ANNOUNCED that the Company has partnered with AFT Pharmaceuticals (ASX: AFP) to launch over-the-counter (OTC) pharmaceuticals in China. The OTC medications will be sold through the Kiwi Health Global Flagship store on Tmall Global, an online platform.
The store is registered under the Chinese cross-border e-commerce (CBEC) OTC pilot scheme. Under the scheme, this is the first New Zealand direct to consumer OTC marketplace in China. The launch will be completed over two phases, and the product portfolio will be expanded to include AFT Pharmaceuticals’ patented pain relief medication Maxigesic and five other OTC products.
RooLife Group’s Role
ROOLIFE GROUP will oversee digital marketing and store operation of the store. The Company will also ensure the sale of AFT Pharmaceuticals’ products including vitamin C and D lipo sachets, Loraclear hay fever relief, Ferro sachets, Kiwisoothe, Histaclear non-drowsy allergy relief, and Crystalwash Extend. In addition, RooLife Group will also be responsible for the end-to-end approval process to ensure AFT Pharmaceuticals can sell its OTC products in China.
Commenting on the partnership, RooLife MANAGING DIRECTOR BRYAN CARR said, “The partnership with AFT Pharmaceuticals puts us at the forefront. We can directly service the strong demand for international OTC products from Chinese consumers. Since the partnership leverages our experience in Chinese e-commerce and market and AFT Pharmaceuticals’ pharmaceutical experience, it represents an excellent achievement for both.”
